Grazyna Liebérman
Genentech · 10 works · 2,281 citations · h-index 7
Top works
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
- Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
- Circulating D‐dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma
- Application of Bayesian approaches in drug development: starting a virtuous cycle
- Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer
- Effect of Cardiac Dysfunction on Treatment Outcomes in Women Receiving Trastuzumab for HER2-Overexpressing Metastatic Breast Cancer
- Assessing function of electronic health records for real-world data generation
- An industry statistician's perspective on PHC drug development
- The use of phase 2 interim analysis to expedite drug development decisions
- An Industry Statistician’s Perspective on Personalized Health Care Drug Development